UNH

Unitedhealth Group
D

UNH

Arincen63/100B
409.28
USD
5.31
(1.31%)
Post Trading·411.20USD+1.92(+0.47%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 2.28Revenue estimate 112.26B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Unitedhealth Group operating income 1985–2026

Unitedhealth Group's operating income in Q3 FY2026, the three months to 30 September 2026, was 6.56B USD, up 52.1% on the same quarter a year before. Unitedhealth Group's operating income over the last twelve months was 23.92B USD, down 9.2% on the twelve months before. In fiscal year 2025 it was 18.96B USD, down 41.3% on the year before.

Last updated 4 Nov 2026 · Next report 20 Jan 2027

Operating income

Operating income · +5.6% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 202623.92B-9.23%5.32%102.58B22.81%27.99B
FY202531 Dec 202518.96B-41.26%4.24%82.92B18.53%23.06B
FY202431 Dec 202432.29B-0.22%8.07%89.40B22.33%28.08B
FY202331 Dec 202332.36B+13.80%8.71%90.96B24.48%36.33B
FY202231 Dec 202228.44B+18.63%8.77%79.62B24.56%31.84B
FY202131 Dec 202123.97B+6.99%8.33%69.65B24.22%27.07B
FY202031 Dec 202022.41B+13.82%8.71%67.00B26.06%25.30B
FY201931 Dec 201919.69B+13.50%8.13%57.60B23.79%22.41B
FY201831 Dec 201817.34B+14.04%7.67%53.85B23.80%19.77B
FY201731 Dec 201715.21B+17.63%7.56%47.01B23.37%17.45B
FY201631 Dec 201612.93B+17.32%7.00%43.39B23.47%14.99B
FY201531 Dec 201511.02B+7.27%7.01%37.03B23.57%12.71B
FY201431 Dec 201410.27B+6.77%7.87%33.43B25.62%11.75B
FY201331 Dec 20139.62B+3.99%7.86%30.36B24.79%11.00B
FY201231 Dec 20129.25B+9.33%8.37%27.87B25.19%10.56B
FY201131 Dec 20118.46B+7.63%8.31%9.59B9.41%9.59B
FY201031 Dec 20107.86B+23.67%8.35%8.93B9.48%8.93B
FY200931 Dec 20096.36B+20.82%7.30%7.35B8.43%7.35B
FY200831 Dec 20085.26B-32.95%6.48%19.35B23.83%6.24B
FY200731 Dec 20077.85B+12.39%10.41%19.23B25.49%8.65B
FY200631 Dec 20066.98B+37.48%9.76%16.76B23.43%7.65B
FY200531 Dec 20055.08B+23.87%10.94%12.14B26.15%5.53B
FY200431 Dec 20044.10B+53.54%11.02%-28.64B-76.96%4.48B
FY200331 Dec 20032.67B+22.19%9.35%7.85B27.49%30.00B
FY200231 Dec 20022.19B+39.59%8.74%6.83B27.29%2.44B
FY200131 Dec 20011.57B+30.50%6.68%1.83B7.81%1.83B
FY200031 Dec 20001.20B+27.25%5.68%4.97B23.52%1.45B
FY199931 Dec 1999943.00M—4.82%4.52B23.10%38.41B
FY199831 Dec 1998-42.00M-105.66%-0.24%3.83B22.08%868.00M
FY199731 Dec 1997742.00M+24.41%6.29%3.25B27.57%888.00M
FY199631 Dec 1996596.41M+29.43%5.92%2.89B28.73%744.54M
FY199531 Dec 1995460.79M-8.94%8.13%1.74B30.68%709.04M
FY199431 Dec 1994506.05M+65.43%13.43%1.13B29.87%606.07M
FY199331 Dec 1993305.90M+72.14%12.10%764.70M30.26%356.10M
FY199231 Dec 1992177.70M+54.39%12.32%482.60M33.47%208.80M
FY199131 Dec 1991115.10M+108.14%13.59%313.40M37.00%129.40M
FY199031 Dec 199055.30M+113.51%9.13%221.80M36.63%65.90M
FY198931 Dec 198925.90M—6.29%168.40M40.87%33.70M
FY198831 Dec 1988-7.70M—-1.77%129.20M29.78%600.00K
FY198731 Dec 1987-20.70M-349.40%-4.75%136.90M31.44%-12.90M
FY198631 Dec 19868.30M+102.44%3.90%89.80M42.18%11.80M
FY198531 Dec 19854.10M—4.05%49.00M48.42%5.70M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Unitedhealth Group's operating income

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.